RADIOPROTECTANT COPPER COMPLEX, CU(11)(3,5-DIPS)2
RADIOPROTECTANT COPPER COMPLEX, CU(11)(3,5-DIPS)2
批准号:
3180235
负责人:
John Robert Joseph Sorenson
金额:
$9.92万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-09-30 至 1988-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Long term objectives are to evaluate Bis 3,5-diisopropylsaliclatocopper
(II) Cu(II)(3,5-dips)2 treatment regimens for radioprotection of cells
grown in culture and mice irradiated with clinically relevant doses of X-
and gamma-radiation (40-170 rads/minute to deliver 800 to 1000 rads), and
evaluate effects of radiation and treatment (0, 60, 80, or 100 mg/kg) on
essential metalloelement metabolism and immunocompetency of mice.
Specific aims of this proposal are to synthesize sufficient quantities of
Cu(II) (3,5-dips)2 to enable studies of its radioprotectant activity.
Radioprotectant activity will be determined by measuring survival of
irradiated cultured cells and whole-body irradiated mice. Survival and
treatment regimen will be correlated for irradiated cells grown in
culture. Altered essential metalloelement metabolism and immunocompetency
will be determined for irradiated and treated mice. Survival, alteration
of plasma, liver, spleen, intestine, brain, and bone marrow copper content
as well as immunocompetency will be correlated for irradiated and treated
mice.
Routine synthetic procedures will be used to synthesize Cu(II)(3,5-dips)2.
Atomic absorption spectrophotometric methods will be used to determine
tissue copper content. Colony formation, as measured with Puck-Marcus
single cell techniques, will be used to determine irradiated-cell
survival. Survival will also be used to measure the in vivo
radioprotectant activity. Immunocompetency will be determined by
evaluating the abilities of different lymphocyte subclasses to repopulate
hosts with determinations of spleen cell markers, mitogen responsiveness,
and bone marrow colony forming units. Antibody responsiveness will be
measured using the Jerne plaque-forming assay and determinations of
cell-mediated immunity will be measured using oxazolone hypersensitivity
and mixed lymphocyte reactivity. Appropriate statistical programs will be
used to evaluate significance of differences found in these studies.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Combination therapy with CuDIPS, Tween 80 and cyclophosphamide: effects on survival and tumor incidence in SJL/J mice.
CuDIPS、Tween 80 和环磷酰胺联合治疗:对 SJL/J 小鼠生存和肿瘤发生率的影响。
DOI:
--
发表时间:
1990
期刊:
In vivo (Athens, Greece)
影响因子:
--
作者:
[CrispensJr,CG, Sorenson,JR]
通讯作者:
Sorenson,JR
Pharmacokinetic distribution of 67Cu(II)2[3,5-diisopropyl(carboxy-14C)salicylate]4 among murine tissues.
67Cu(II)2[3,5-二异丙基(羧基-14C)水杨酸酯]4 在小鼠组织中的药代动力学分布。
DOI:
10.2174/0929867043363992
发表时间:
2004
期刊:
Current medicinal chemistry
影响因子:
4.1
作者:
[Blincoe,Clifton, Chidambaram,Mani, Salari,Hamid, Bond,KyleB, Evans,DorisT, Gray-Kaufman,RhondaA, Griffey,HalBrent, Tranby,SandraGilbreth, Garner-Johnson,Buffy, Lee,Tina, Sorenson,JohnRJ]
通讯作者:
Sorenson,JohnRJ
Copper complexes stimulate hemopoiesis and lymphopoiesis.
铜络合物刺激造血和淋巴细胞生成。
DOI:
10.1007/978-1-4613-0537-8_18
发表时间:
1989
期刊:
Advances in experimental medicine and biology
影响因子:
--
作者:
[Soderberg,LS, Barnett,JB, Sorenson,JR]
通讯作者:
Sorenson,JR
Treatment of reticulum cell sarcoma in SJL/J mice with Tween 80.
使用 Tween 80 治疗 SJL/J 小鼠网状细胞肉瘤。
DOI:
--
发表时间:
1988
期刊:
Anticancer research
影响因子:
2
作者:
[CrispensJr,CG, Sorenson,JR]
通讯作者:
Sorenson,JR
Radiation recovery agents: Cu(II), Mn(II), Zn(II), or Fe(III) 3,5-diisopropylsalicylate complexes facilitate recovery from ionizing radiation induced radical mediated tissue damage.
辐射恢复剂:Cu(II)、Mn(II)、Zn(II) 或 Fe(III) 3,5-二异丙基水杨酸盐复合物有助于从电离辐射引起的自由基介导的组织损伤中恢复。
DOI:
10.1007/978-1-4684-5730-8_10
发表时间:
1990
期刊:
Advances in experimental medicine and biology
影响因子:
--
作者:
[Sorenson,JJ, Soderberg,LS, Baker,ML, Barnett,JB, Chang,LW, Salari,H, Willingham,WM]
通讯作者:
Willingham,WM
共 11 条
RADIOPROTECTANT COPPER COMPLEX--CU-LL-3,5-DIPS-2
-
批准号:3180234
-
项目类别:
-
资助金额:$9.65万
-
财政年份:1986
-
负责人:John Robert Joseph Sorenson
-
依托单位: